COVAXIN – Page 11 – Express Pharma

Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin

Drug activist group AIDAN raises concerns over EUA for COVAXIN

DCGI approves Covishield and Covaxin for restricted emergency use in India

COVAXIN clinical trials recruit 23,000 subjects

SEC recommends EUA for Covaxin from Bharat Biotech

Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin

Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response

Ocugen and Bharat Biotech to Co-develop COVAXIN for US market

COVAXIN is well tolerated with no serious adverse events in Phase I trials

COVID-19 expedites India’s focus on innovation within pharma: GlobalData